XYLOCAINE ACCORDION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

LIDOCAINE HYDROCHLORIDE

Available from:

AstraZeneca UK Limited

Dosage:

20 Mg/Ml

Pharmaceutical form:

Gel

Authorization date:

2000-04-01

Safety Data Sheet

XYLOCAINE GEL
PH3523
Page 1 of 5
Revision : 13.05.2016
Version : 1.2
SAFETY DATA SHEET
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
PRODUCT IDENTIFIER
XYLOCAINE GEL
DETAILS OF THE SUPPLIER OF
THE SAFETY DATA SHEET
:
ASTRAZENECA PTY LTD
PO Box 131
Alma Road, North Ryde
NSW 2113
AUSTRALIA
[phone]
Emergency Telephone
[phone]
[e-mail]
ALTERNATIVE NAMES
Xylocaine Accordion Gel 2%
Xylocaine 2% Jelly
Xylocaine Gel 2%
CAS No.
:
Not applicable
Use
:
topical anaesthetic
2. HAZARDS IDENTIFICATION
This mixture is not classified as hazardous for supply/use according
to GHS v 4.0. May produce a reduced heart
rate and reduction in blood pressure with a resulting feeling of
dizziness.
3. COMPOSITION/INFORMATION ON INGREDIENTS
MIXTURE:
COMPONENT
%
CAS NO.
Lidocaine hydrochloride
monohydrate
2
6108-05-0
HAZARD CLASS #
CATEGORY
HAZARD STATEMENTS
#
Acute toxicity
3
H301
# Refer to Section 16 'Other Information'
4. FIRST-AID MEASURES
DESCRIPTION OF FIRST AID MEASURES
Inhalation
:
Remove patient from exposure. Obtain medical attention if ill effects
occur.
Skin Contact
:
Remove contaminated clothing. Wash skin with soap and water. If
symptoms (irritation or
blistering) occur obtain medical attention.
Eye Contact
:
Irrigate with eyewash solution or clean water, holding the eyelids
apart, for at least 10
minutes. Obtain medical attention.
Ingestion
:
Wash out mouth with water and give 200-300ml of water to drink. Do NOT
induce vomiting
as a First-Aid measure. Obtain medical attention.
XYLOCAINE GEL
PH3523
Page 2 of 5
Revision : 13.05.2016
Version : 1.2
MOST IMPORTANT SYMPTOMS AND EFFECTS, BOTH ACUTE AND DELAYED
Refer to sections 2 and 11
INDICATION OF ANY IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT
NEEDED
Symptomatic treatment and supportive therapy as indicated.For further
detail consult the prescribing information.
5. FIRE-FIGHTING MEASURES
Extinguishing Media (suitable)
:
water spray, foam, dry powder or CO2.
Extinguishing Media (unsuitable)